The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)

Overview of attention for article published in BMC Nephrology, May 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 8,279 followers.

RT @NierenMark_us: 6/ the biggest trial that studied the effect of spironolactone on CNI toxicity is the SPIREN-Trial https://t.co/2e0hzThs…

RT @NierenMark_us: 6/ the biggest trial that studied the effect of spironolactone on CNI toxicity is the SPIREN-Trial https://t.co/2e0hzThs…

RT @NierenMark_us: 6/ the biggest trial that studied the effect of spironolactone on CNI toxicity is the SPIREN-Trial https://t.co/2e0hzThs…

6/ the biggest trial that studied the effect of spironolactone on CNI toxicity is the SPIREN-Trial https://t.co/2e0hzThsGp

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.